New Mutations Involved in Colistin Resistance in Acinetobacter Baumannii

Bingbing Sun,Haiyan Liu,Yu Jiang,Lei Shao,Sheng Yang,Daijie Chen
DOI: https://doi.org/10.1128/msphere.00895-19
2020-01-01
mSphere
Abstract:Acinetobacter baumannii is an important Gram-negative opportunistic pathogen commonly infecting critically ill patients. It possesses a remarkable ability to survive in the hospital environment and acquires resistance determinants corresponding to a wide range of antibacterial agents. Given that the current treatment options for multidrug resistant A. baumannii are extremely limited, colistin administration has become the treatment of last resort. However, colistin-resistant A. baumannii strains have recently been reported. The mechanism of resistance to colistin in A. baumannii has rarely been reported. Here, we found two novel mutations in pmrA (I13M) and pmrB (Q270P) that caused colistin resistance. It is also first reported here that the presence of miaA with a I221V mutation enhanced the colistin resistance of pmrA P102R .
What problem does this paper attempt to address?